Denosumab: an Emerging Therapy in Pediatric Bone Disorders.

Denosumab: an Emerging Therapy in Pediatric Bone Disorders.
复制标题

DOI:
10.1007/s11914-017-0380-1
复制
发表时间:
2017-08
影响因子:
4.3
通讯作者:
Boyce AM
Boyce AM
中科院分区:
医学2区
文献类型:
--
作者:
Boyce AM

文献摘要

参考文献

被引文献

相似文献

地诺单抗是核因子κB受体活化因子配体(RANKL)的抑制剂,已成为骨骼疾病的一种重要的新型治疗方法。本文探讨了地诺单抗在儿童中的应用。 地诺单抗用于治疗患有骨质疏松症、骨转移和骨巨细胞瘤的成人,已有大量的安全性和有效性数据。儿科数据有限;然而,有证据表明地诺单抗可能有利于降低儿童的骨转换、增加骨密度以及预防某些骨骼肿瘤的生长。地诺单抗对骨转换的影响在停药后可迅速逆转,这与双膦酸盐有重要区别。骨转换反弹已导致数名儿科患者出现严重的高钙血症。 地诺单抗是治疗儿科骨骼疾病的一种有前景的疗法。目前,与骨转换反弹和矿物质内稳态相关的安全性问题影响了地诺单抗在儿童中的使用。需要进行研究以确定是否以及如何减轻这些影响。
Denosumab is an inhibitor of receptor activator of nuclear factor kappa-B ligand (RANKL), and has emerged as an important novel therapy for skeletal disorders. This article examines the use of denosumab in children. Considerable safety and efficacy data exists for denosumab treatment of adults with osteoporosis, bone metastases, and giant cell tumors. Pediatric data is limited; however, evidence suggests denosumab may be beneficial in decreasing bone turnover, increasing bone density, and preventing growth of certain skeletal neoplasms in children. Denosumab’s effect on bone turnover is rapidly reversible after drug discontinuation, representing a key difference from bisphosphonates. Rebound increased bone turnover has led to severe hypercalcemia in several pediatric patients. Denosumab is a promising therapy for pediatric skeletal disorders. At present, safety concerns related to rebounding bone turnover and mineral homeostasis impact use of denosumab in children. Research is needed to determine if and how these effects can be mitigated.
DOI: 10.1159/000381045
发表时间: 2015-01-01
期刊: CALCIUM AND BONE DISORDERS IN CHILDREN AND ADOLESCENTS, 2ND EDITION
影响因子: --
作者:
Hogler, Wolfgang;Ward, Leanne
通讯作者: Ward, Leanne
DOI: 10.1359/jbmr.081113
发表时间: 2009-02-01
影响因子: 6.2
作者:
Gerstenfeld, Louis C.;Sacks, Daniel J.;Einhorn, Thomas A.
通讯作者: Einhorn, Thomas A.
DOI: 10.1016/j.ejca.2015.04.017
发表时间: 2015-07-01
影响因子: 8.4
作者:
Diel, Ingo J.;Body, Jean-Jacques;Braun, Ada
通讯作者: Braun, Ada
DOI: 10.1210/jc.2007-2814
发表时间: 2008-06-01
影响因子: 5.8
作者:
Bone, Henry G.;Bolognese, Michael A.;Martin, Javier San
通讯作者: Martin, Javier San
DOI: 10.1200/jco.2010.31.3304
发表时间: 2011-03-20
影响因子: 45.3
作者:
Henry, David H.;Costa, Luis;Yeh, Howard
通讯作者: Yeh, Howard